Core Viewpoint - The brokerage asset management industry is undergoing significant changes due to two major events: the transition of public collective investment schemes ending by the end of 2025 and the obstacles faced in obtaining public fund licenses for brokerage asset management [1][2]. Group 1: Strategic Focus Areas - "Fixed Income +" and multi-asset allocation are identified as the two strategic focuses for brokerage asset management in 2026, aimed at meeting investor demand for stable returns in a low-interest-rate environment [3][6]. - Companies plan to enhance their competitive edge by developing differentiated strategies in areas such as Fund of Funds (FOF), equity, quantitative strategies, cross-border investments, and retirement products [3][4]. Group 2: Development of "Fixed Income +" Products - Brokerage firms are focusing on building a product lineup with varying risk characteristics in the "Fixed Income +" space, with firms like First Capital Asset Management emphasizing low-volatility products and ESG-focused offerings [4]. - Other firms, such as Caitong Asset Management, are refining their "Fixed Income +" strategies by creating a gradient of products from low to high volatility, while Guoxin Asset Management aims to expand its fixed income strategies while maintaining its traditional credit enhancement advantages [4]. Group 3: Multi-Asset and Diversified Strategies - Many firms are prioritizing multi-asset and diversified strategies, with Guangfa Asset Management planning to leverage its platform and digital capabilities to expand into "Fixed Income +", multi-strategy, and distinctive equity products [5]. - Caitong Asset Management is increasing its focus on QDII and retirement products, while Zhongtai Asset Management is set to emphasize FOF, active equity, and "Fixed Income +" products in 2026 [5]. Group 4: Passive Investment Tools - The trend towards passive investment is becoming increasingly significant, with firms developing index-enhanced and ETF products to improve asset allocation efficiency and reduce costs for clients [7][8]. - Companies like Guojin Asset Management are actively developing tool-based FOF and index-enhanced strategies, while Caitong Asset Management is working on a quantitative index-enhanced product line [8]. Group 5: Alternative Assets for Revenue Expansion - In the current low-interest-rate environment, alternative assets such as REITs, commodities, and derivatives are gaining traction as they offer low correlation with traditional assets and potential for enhanced returns [9][10]. - First Capital Asset Management has been a pioneer in public REITs investment and plans to deepen its involvement in this area, while Caitong Asset Management is focusing on a diversified investment approach that includes ABS and REITs [9][10].

Group 1 - The core product ABSK021 of He Yu Pharmaceutical has recently received approval from the NMPA, marking it as China's first self-developed drug for the treatment of tenosynovial giant cell tumor (TGCT) [1] - The successful approval of ABSK021 signifies the company's transition from clinical research to commercialization, validating its full-cycle innovation capability from target selection to market approval [2] - Long-term follow-up data indicates that the response rate of patients treated with ABSK021 improves over time, with a notable overall response rate (ORR) of 76.2% at a median follow-up of 14.3 months in the Phase III trial [3] Group 2 - The successful launch of ABSK021 enhances the company's pipeline value and is expected to generate stable cash flow, especially with the collaboration with Merck in commercialization [1][2] - The clinical data shows that ABSK021 has a strong safety and efficacy profile, which, combined with Merck's marketing capabilities, is anticipated to contribute significantly to the company's sales revenue [3]

Group 1 - The core product ABSK021 has received approval from NMPA for the treatment of symptomatic adult TGCT patients, marking it as the first self-developed drug for this condition in China [1][2] - The successful approval of ABSK021 signifies the company's transition from clinical research to commercialization, validating its full-cycle innovation capability from target selection to market approval [2][3] - Long-term follow-up data indicates that the response rate for patients treated with ABSK021 improves over time, with a reported overall response rate (ORR) of 76.2% at a median follow-up of 14.3 months in the Phase III trial [3] Group 2 - The collaboration with Merck is expected to enhance the commercial potential of ABSK021, providing a stable cash flow for the company [1][3] - The successful launch of ABSK021 is anticipated to significantly contribute to the company's revenue, especially given the lack of suitable innovative therapies for TGCT [3]

Group 1 - The fund is named "Penghua ChiNext New Energy ETF Initiated Link Fund" with two classes: A and C [8][9] - The fund operates as a contractual open-end ETF link fund [8] - The maximum fundraising scale during the fundraising period is set at 500 million RMB, excluding interest accrued during the fundraising period [10][27] Group 2 - The fundraising period is from January 19, 2026, to February 6, 2026 [15] - Investors can subscribe multiple times during the fundraising period, but once a subscription application is accepted, it cannot be withdrawn [10][11] - The minimum subscription amount for each fund trading account is 1 RMB, with specific rules for direct sales and other sales institutions [24][25] Group 3 - The fund is open to individual investors, institutional investors, and qualified foreign investors who meet legal requirements [12] - The fund management company is Penghua Fund Management Co., Ltd., and the custodian is Zhongtai Securities Co., Ltd. [54][55] - The fund's contract will take effect if the amount subscribed by the initiator reaches at least 10 million RMB and the initiator commits to holding the fund shares for no less than three years [15][50] Group 4 - The fund's A class shares will incur subscription fees, while C class shares will not [17] - Interest generated from effective subscription funds during the fundraising period will be converted into corresponding fund shares for the fund shareholders [18][48] - The fund's contract will automatically terminate if the net asset value falls below 200 million RMB three years after the contract takes effect [52]

Group 1 - The "Second Sina Finance Golden Kylin Best Investment Advisor" selection commenced in June 2025, attracting over 70 institutions and more than 15,000 investment advisors nationwide [1][3] - The evaluation process lasted over six months, involving multi-dimensional assessments and competitions, resulting in over a hundred top elite investment advisors emerging [1][3] - The awards for the "Second Sina Finance Golden Kylin Best Investment Advisory Service Institution" were announced, highlighting the recognition of outstanding service providers in the investment advisory sector [1][4]

专题：2026全球与中国资本市场展望论坛 专题：2026全球与中国资本市场展望论坛 2026年1月15日，"2026全球与中国资本市场展望论坛暨金麒麟最佳财富管理机构、最佳投资顾问盛 典"举办，论坛邀请了多位顶尖专家与思想领袖，他们从宏观生态、市场策略与投资展望等多个维度， 为我们勾勒2026年的前景蓝图。 同时，会议隆重揭晓了2025金麒麟最佳财富管理机构荣誉。 2026年1月15日，"2026全球与中国资本市场展望论坛暨金麒麟最佳财富管理机构、最佳投资顾问盛 典"举办，论坛邀请了多位顶尖专家与思想领袖，他们从宏观生态、市场策略与投资展望等多个维度， 为我们勾勒2026年的前景蓝图。 同时，会议隆重揭晓了2025金麒麟最佳财富管理机构荣誉。 新浪财经2025金麒麟·年度最佳全域流量运营先锋奖荣誉榜如下： 随着新"国九条"政策落地，财富管理能力从"加分项"跃升为券商高质量发展的"必答题"。聚焦主业、服 务居民财富增长，已成为行业核心使命。 在此背景下，新浪财经举办2025金麒麟最佳财富管理机构评选。本届评选全面升级，设八大奖项，旨在 从综合实力、成长动能、科技赋能与生态构建等多维度，全景扫描券商财富管理业务的 ...

Core Insights - The recent upgrade of the QiFuTong App by Zhongtai Securities focuses on enhancing the ETF section, integrating professional capabilities from leading public fund institutions, and introducing new features for a comprehensive index investment experience Group 1: Functionality and User Experience - The upgrade addresses investor needs and industry pain points by creating modules like "Buy Global," "Buy Industry," and "Monthly Selections," making investment more aligned with market dynamics and simpler to operate [3] - The "Find Opportunities" module categorizes investment opportunities into "Long-term Opportunities" and "Short-term Hotspots," focusing on national strategies and market signals to provide actionable trading references [5] - The "Follow Advisors" module targets common decision-making challenges faced by ordinary investors, offering access to professional investment strategies tailored to different risk-return profiles [7] - The "Market Observation" module provides a centralized display of ETF rankings, enabling investors to efficiently navigate market data and trends without complex operations [9] Group 2: Collaboration and Ecosystem Development - Zhongtai Securities collaborates with leading public fund institutions to create a new ecosystem service alliance, enhancing value through joint research, content creation, and service integration [12] - The partnership with Wanji Fund leverages integrated resources to improve customer investment experiences, focusing on innovative products in broad-based, thematic, and Smart Beta investments [12] Group 3: Technological Empowerment - The upgrade represents a significant step in Zhongtai Securities' digital and intelligent transformation in wealth management, aiming to set a new standard for ETF ecosystem services [12] - The "Zhongtai Wealth 30" brand, including "Zhongtai ETF 30," aims to provide efficient and professional index investment solutions through a comprehensive service system [12][13] - The company plans to continue enhancing financial technology capabilities to create lasting value for investors and contribute to the high-quality development of China's index investment ecosystem [13]

中泰证券（600918）发布研报称，"价格战"转向"价值战"背景下，快递业市场份额有望逐步向服务品质 更优、管理能力更强、网络健康度更好的快递企业集中，同时该等企业有望凭借自身资源优势实现更为 显著的降本增效;重点跟踪监管力度、量价表现及头部企业竞争策略变化情况。个股方面重点关注中通 快递-W(02057)、圆通速递（600233）(600233.SH)。建议关注申通快递（002468）(002468.SZ)、韵达股 份（002120）(002120.SZ)及顺丰控股（002352）(002352.SZ)。 中泰证券主要观点如下： 3)行业端：行业件量增速放缓下，价值竞争成关键。"反内卷"背景下，快递价格理性回归，快递轻小件 化趋势减弱，同时电商平台合规经营监管强化有望推动快递件量"去泡沫"，行业件量增速中枢下移预期 下(据2026年全国邮政工作会议，2025年快递业务量同比增长13.7%，预计2026年快递业务量同比增长 8%左右)，"降本、提质、增效"的价值竞争成为快递企业打造竞争优势、获取市场份额的关键。 深挖全链路成本下降潜力，末端决胜逐步成为共识 1)中转环节：随着件量规模不断扩大，规模效应带来的边 ...

Core Viewpoint - The express delivery industry is shifting from a "price war" to a "value war," with market share expected to concentrate among companies that offer better service quality, stronger management capabilities, and healthier networks [1] Policy Aspects - The "anti-involution" policy is expected to continue, effectively curbing vicious competition, with multiple provinces raising express delivery prices. From August to November, the single ticket revenue of A-share "Tongda" express companies has shown a continuous upward trend [2] - The "social insurance new regulations" are anticipated to enhance cost-price transmission paths, potentially leading to increased labor costs in the express delivery industry, which may be passed on to consumers through price hikes [2] Industry Aspects - With the growth rate of express delivery volume slowing, value competition is becoming crucial. The rational return of express prices and the reduction of small parcel trends are expected, with the industry volume growth rate forecasted to decrease [3] - The expected growth rates for express delivery volume are 13.7% year-on-year in 2025 and around 8% in 2026, emphasizing the importance of "cost reduction, quality improvement, and efficiency enhancement" for companies to gain market share [3] Cost Reduction Potential - In the transit segment, the marginal cost reduction effects from scale are diminishing, with major franchise express companies focusing on optimizing routes and improving sorting efficiency. As of H1 2025, the single ticket transit cost for "Tongda" express companies has dropped to approximately 0.60 yuan [4] - In the last-mile delivery segment, which significantly impacts user experience and logistics efficiency, there remains substantial potential for cost optimization through automation and innovation. The cost burden for new technologies is primarily borne by franchisees, making the performance of these networks critical [4]

Group 1 - The market is expected to maintain a "theme rotation" pattern, driven by increased capital inflow and enhanced investor confidence, particularly in the technology sector [2][8] - Long-term capital and policy support are providing necessary liquidity conditions, making the overall downside risk manageable [8] - The market is unlikely to experience a uniform upward trend, but structural opportunities are expected to remain active, with funds rapidly rotating among different industry themes [2][8] Group 2 - The total market turnover reached 3.65 trillion yuan, an increase of 496 billion yuan compared to the previous day [7] - The number of stocks that rose, remained flat, and fell in the market was 1,622, 119, and 3,729 respectively [7] - The top three sectors for net capital inflow were pharmaceuticals and biotechnology (+39.91 billion yuan), beauty and personal care (+1.15 billion yuan), and oil and petrochemicals (+0.82 billion yuan) [7]